Comparison of Rimegepant and Placebo for Pain in IBS | MicrobiomeTrials← Back to trialsNCT06221111
Comparison of Rimegepant and Placebo for Pain in IBS
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2024-06-06Est. Completion: 2025-05-30
Enrollment target: 39 participants Locations- Mayo Clinic in Rochester, Rochester, Minnesota, United States
Other microbiome trials you might be interested in
FibromyalgiaDiet, Gluten-Free
The purpose of this study is to evaluate the efficacy of two diets - gluten-free and low-FODMAP diet- in relieving sympt…
Montreal, CanadaCompleted Jun 15, 2022
ConstipationProbioticProbiotic Intervention
Constipation is a prevalent gastrointestinal condition. Beyond simple lifestyle measures (e.g. increasing fibre intake, …
London, United KingdomCompleted Jul 20, 2026
Recruiting
Irritable Bowel Syndrome (IBS)
Randomized, single-blind, sham-controlled crossover study evaluating the efficacy and safety of transcutaneous auricular…
Multiple LocationsEst. completion Dec 31, 2028